|
FR2696462B1
(fr)
*
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé d'obtention de la désacétyl-10 baccatine III.
|
|
ATE502664T1
(de)
|
1993-07-19 |
2011-04-15 |
Angiotech Pharm Inc |
Herstellungsmethode eines stents mit anti- angiogener zusammensetzung
|
|
DE59409093D1
(de)
*
|
1993-11-02 |
2000-02-24 |
Rhone Poulenc Rorer Gmbh |
Verfahren zum auftrennen eines gemisches
|
|
FR2714053B1
(fr)
*
|
1993-12-22 |
1996-03-08 |
Pf Medicament |
Procédé d'extraction et d'isolement de la 10-désacétylbaccatine III.
|
|
CN1112433A
(zh)
*
|
1994-05-24 |
1995-11-29 |
郭明 |
红豆杉属植物提取物及其应用
|
|
CA2178541C
(en)
|
1995-06-07 |
2009-11-24 |
Neal E. Fearnot |
Implantable medical device
|
|
FR2736355B1
(fr)
*
|
1995-07-07 |
1997-11-07 |
Pf Medicament |
Procede d'extraction et d'isolement de la 10-desacetylbaccatine iii
|
|
US5750736A
(en)
*
|
1996-07-11 |
1998-05-12 |
Napro Biotherapeutics, Inc. |
Method for acylating 10-deacetylbaccatin III selectively at the c-10 position
|
|
US5965752A
(en)
*
|
1996-08-23 |
1999-10-12 |
Institut National De La Recherche Scientifique |
Preparative scale isolation and purification of taxanes
|
|
EP1019347B1
(en)
*
|
1997-08-21 |
2003-03-19 |
Florida State University |
Method for the synthesis of taxanes
|
|
US6002024A
(en)
*
|
1998-07-27 |
1999-12-14 |
Dabur Research Foundation |
Process for the isolation of 14β-hydroxy-10-deacetyl baccatin-III
|
|
US6136989A
(en)
*
|
1998-12-30 |
2000-10-24 |
Phytogen Life Sciences, Incorporated |
Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
|
|
US6495705B2
(en)
|
2000-03-16 |
2002-12-17 |
Napro Biotherapeutics, Inc. |
Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
|
|
US6281368B1
(en)
|
2000-03-16 |
2001-08-28 |
Napro Biotherapeutics, Inc. |
Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III
|
|
CA2307393A1
(en)
|
2000-05-01 |
2001-11-01 |
The University Of British Columbia |
Ginsenoside chemotherapy
|
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
|
EP1418945A2
(en)
|
2001-03-13 |
2004-05-19 |
Angiotech Pharmaceuticals, Inc. |
Micellar drug delivery vehicles and uses thereof
|
|
DK1392254T3
(da)
*
|
2001-04-20 |
2007-07-02 |
Univ British Columbia |
Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler
|
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
|
AU2003300076C1
(en)
|
2002-12-30 |
2010-03-04 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
|
CN101039957A
(zh)
|
2003-05-16 |
2007-09-19 |
因特缪恩公司 |
合成的趋化因子受体配体及其使用方法
|
|
WO2005040758A2
(en)
|
2003-10-24 |
2005-05-06 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
|
US7846940B2
(en)
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
|
US8003122B2
(en)
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
|
PT1778660E
(pt)
*
|
2004-07-02 |
2009-03-10 |
Ivax Cr A S |
Processo para a separação de paclitaxel e cefalomanina
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
WO2006089209A2
(en)
|
2005-02-17 |
2006-08-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
|
|
WO2007062036A2
(en)
|
2005-11-21 |
2007-05-31 |
Med Institute, Inc. |
Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent
|
|
US8168216B2
(en)
|
2006-03-22 |
2012-05-01 |
Medigene Ag |
Treatment of triple receptor negative breast cancer
|
|
EP2043704B2
(en)
|
2006-06-30 |
2017-04-19 |
Cook Medical Technologies LLC |
Methods of manufacturing and modifying taxane coatings for implantable medical devices
|
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
|
US8273404B2
(en)
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
|
EP2296645B1
(en)
|
2008-05-22 |
2014-11-19 |
Galera Therapeutics, LLC |
Combination antitumor therapy
|
|
US20110172293A1
(en)
|
2008-07-08 |
2011-07-14 |
Fish Jason E |
Methods and Compositions for Modulating Angiogenesis
|
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
|
WO2013069027A1
(en)
|
2011-09-26 |
2013-05-16 |
Fresenius Kabi Oncology Ltd. |
Processes for the preparation of cabazitaxel involving c(7) -oh and c(13) -oh silylation or just c(7) -oh silylation
|
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
|
IN2015DN00552A
(fi)
|
2012-07-19 |
2015-06-26 |
Redwood Bioscience Inc |
|
|
AU2013341711A1
(en)
|
2012-11-12 |
2015-05-21 |
Redwood Bioscience, Inc. |
Compounds and methods for producing a conjugate
|
|
CN103804326A
(zh)
*
|
2012-11-15 |
2014-05-21 |
刘胜远 |
一种从含10-去乙酰基巴卡亭ⅲ的浸膏分离和提纯10-去乙酰基巴卡亭ⅲ的方法
|
|
KR102332790B1
(ko)
|
2013-02-15 |
2021-12-01 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
키메라 항원 수용체 및 이의 이용 방법
|
|
CN103145652B
(zh)
*
|
2013-03-05 |
2015-09-30 |
无锡尔云科技有限公司 |
一种从红豆杉属植物中提取紫杉醇及其衍生物的方法
|
|
WO2014160185A2
(en)
|
2013-03-14 |
2014-10-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
|
AU2014354643B2
(en)
|
2013-11-27 |
2020-03-05 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
|
CA2940269C
(en)
|
2014-02-19 |
2022-08-16 |
Aviv Therapeutics, Inc. |
Mitochondrial aldehyde dehydrogenase 2 (aldh2) binding polycyclic amides and their use for the treatment of cancer
|
|
US10517961B2
(en)
|
2015-09-25 |
2019-12-31 |
ZY Therapeutics, Inc. |
Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
|
|
US10654875B2
(en)
|
2015-11-12 |
2020-05-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
|
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
|
EP3448885A4
(en)
|
2016-04-26 |
2020-01-08 |
R.P. Scherer Technologies, LLC |
ANTIBODY CONJUGATES AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
KR102783452B1
(ko)
|
2016-06-01 |
2025-03-19 |
세르비에 아이피 유케이 리미티드 |
폴리알킬렌 옥시드-아스파라기나제의 제형, 및 그의 제조 및 사용 방법
|
|
TWI852903B
(zh)
|
2017-01-05 |
2024-08-21 |
杏國新藥股份有限公司 |
胰臟癌治療
|
|
AU2018211081B2
(en)
|
2017-01-18 |
2025-01-02 |
Bioatla, Inc. |
Chimeric antigen receptors against Axl or Ror2 and methods of use thereof
|
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
CN118652192A
(zh)
|
2017-05-24 |
2024-09-17 |
德克萨斯州大学系统董事会 |
用于抗体药物缀合物的接头
|
|
CN111902147A
(zh)
|
2018-01-31 |
2020-11-06 |
加莱拉实验室有限责任公司 |
五氮杂大环状环配合物和基于铂的抗癌剂的组合癌症治疗
|
|
EP3773633A4
(en)
|
2018-04-06 |
2022-01-26 |
The Regents of The University of California |
METHODS OF TREATMENT OF GLIOBLASTOMA
|
|
CA3096202A1
(en)
|
2018-04-06 |
2019-10-10 |
The Regents Of The University Of California |
Methods of treating egfrviii expressing glioblastomas
|
|
KR20210009315A
(ko)
|
2018-04-11 |
2021-01-26 |
오하이오 스테이트 이노베이션 파운데이션 |
안약 전달용 서방형 마이크로 입자를 이용한 방법 및 조성물
|
|
CN108904137A
(zh)
*
|
2018-05-27 |
2018-11-30 |
肖军威 |
一种卫生巾芯片的制备方法及卫生巾芯片的加工设备
|
|
US11897928B2
(en)
|
2018-07-18 |
2024-02-13 |
Manzanita Pharmaceuticals, Inc. |
Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
|
|
TW202038994A
(zh)
|
2019-01-14 |
2020-11-01 |
美商醫格耐免疫治療公司 |
重組痘瘡病毒及其使用方法
|
|
EP3923967A1
(en)
|
2019-02-14 |
2021-12-22 |
Ignite Immunotherapy, Inc. |
Recombinant vaccinia virus and methods of use thereof
|
|
KR20220004653A
(ko)
|
2019-04-02 |
2022-01-11 |
켄조케티 바이오테크놀러지 인코포레이티드 |
유출 펌프-암 항원 다중특이적 항체 및 그것과 관련된 조성물, 시약, 키트 및 방법
|
|
CN110317183B
(zh)
*
|
2019-08-08 |
2021-03-12 |
无锡紫杉药业有限公司 |
一种红豆杉天然提取产物的纯化方法
|
|
IL293627A
(en)
|
2019-12-12 |
2022-08-01 |
Ignite Immunotherapy Inc |
Variant oncolytic vaccinia virus and methods of use thereof
|
|
BR112022013870A2
(pt)
|
2020-01-29 |
2022-09-13 |
Kenjockety Biotechnology Inc |
Anticorpos anti-mdr1 e usos dos mesmos
|
|
WO2021247423A1
(en)
|
2020-06-04 |
2021-12-09 |
Kenjockety Biotechnology, Inc. |
Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
|
US20230212305A1
(en)
|
2020-06-04 |
2023-07-06 |
Kenjockety Biotechnology, Inc. |
Anti-abcg2 antibodies and uses thereof
|
|
CA3189291A1
(en)
|
2020-07-14 |
2022-01-20 |
Pfizer Inc. |
Recombinant vaccinia virus
|
|
JP7747741B2
(ja)
|
2020-09-02 |
2025-10-01 |
ウィリアム ロバート アラスーン リビング トラスト デイテッド オーガスト 29, 2016 |
抗ａｂｃｃ１抗体及びその使用
|
|
US20240010747A1
(en)
|
2020-11-13 |
2024-01-11 |
Kenjockety Biotechnology, Inc. |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
|
JP2023551203A
(ja)
|
2020-11-20 |
2023-12-07 |
アール．ピー．シェーラー テクノロジーズ、エルエルシー |
抗体－薬物コンジュゲートのためのグリコシド二重切断リンカー
|
|
CN112694458A
(zh)
*
|
2020-12-29 |
2021-04-23 |
重庆臻源红豆杉发展有限公司 |
一种10-去乙酰基巴卡亭ⅲ提取纯化方法
|
|
WO2023114658A1
(en)
|
2021-12-13 |
2023-06-22 |
Kenjockety Biotechnology, Inc. |
Anti-abcb1 antibodies
|
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|